Colgate-Palmolive Company is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. It specializes in the production, distribution and provision of household, health care, personal care and veterinary products.
| Revenue (TTM) | $21.28B |
| Gross Profit (TTM) | $12.91B |
| EBITDA | $5.04B |
| Operating Margin | 20.40% |
| Return on Equity | 231.70% |
| Return on Assets | 16.10% |
| Revenue/Share (TTM) | $26.58 |
| Book Value | $0.36 |
| Price-to-Book | 272.40 |
| Price-to-Sales (TTM) | 3.61 |
| EV/Revenue | 3.977 |
| EV/EBITDA | 21.90 |
| Quarterly Earnings Growth (YoY) | 3.30% |
| Quarterly Revenue Growth (YoY) | 4.60% |
| Shares Outstanding | $794.92M |
| Float | $746.10M |
| % Insiders | 0.15% |
| % Institutions | 86.69% |
Volatility is currently expanding
The Fund returned 3.18% compared to a 2.61% return for the Russell 1000 Value Index. Key contributors include Microsoft, Salesforce and Thermo Fisher Scientific. Key detractors include Aon, Carrier Global and Builders FirstSource.
Both consumer giants beat earnings, yet their margins are moving in opposite directions as oil prices climb and a cautious U.S. shopper holds back. One dividend carries a thin balance sheet buffer, and retirees need to know which one.
Coca-Cola, Procter & Gamble, and Colgate-Palmolive are attracting investors seeking reliable earnings and dividends amid political uncertainty. Recent earnings results demonstrate the resilience of their consumer-staples businesses, although growth rates vary considerably.
When inflation eats into your dividend's buying power, pricing power becomes the one trait separating stocks that keep up from those that quietly fall behind.
Colgate-Palmolive is rated Buy, supported by strong execution, margin expansion, and a valuation below its historical average. Hill's Pet Nutrition division drives growth, benefiting from premium product innovation, therapeutic offerings, and expansion into fresh pet food categories. Premium innovation, increased advertising, and robust emerging market exposure are accelerating organic sales and positioning CL for long-term growth.
Colgate-Palmolive Company (NYSE:CL) on Friday reported better-than-expected third-quarter results. The company narrowed its sales guidance range while raising profitability expectations.
Colgate-Palmolive generates significant free cash flow from its dominant position in global household essentials. Lululemon Athletica maintains a liquid balance sheet and high net margins while navigating leadership changes.
Colgate-Palmolive NYSE: CL said it delivered broad-based organic sales growth and higher earnings in the third quarter of 2026, supported by emerging-market momentum, premium innovation, productivity programs and strong performance at its Hill's pet nutrition business.
Colgate-Palmolive Q3 earnings and sales were just slightly above estimates, but that's not the main takeaway from the report. As I showed earlier this year, gross margin will continue to be the main catalyst for CL, and in that regard, the Q3 report was quite strong. There are some encouraging signs in key segments, which, in combination with the conservative valuation, bode well for future returns.
Colgate-Palmolive Company (CL) Q3 2026 Earnings Call Transcript
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CL and any ticker you trade — then tracks every position and per-strategy win rate.
